Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 599

1.

Adverse event reports following yellow fever vaccination.

Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB.

Vaccine. 2008 Nov 11;26(48):6077-82. doi: 10.1016/j.vaccine.2008.09.009. Epub 2008 Sep 20.

PMID:
18809449
[PubMed - indexed for MEDLINE]
2.

Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Staples JE, Gershman M, Fischer M; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Jul 30;59(RR-7):1-27.

PMID:
20671663
[PubMed - indexed for MEDLINE]
Free Article
3.

Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review.

Thomas RE, Lorenzetti DL, Spragins W, Jackson D, Williamson T.

Vaccine. 2011 Jun 20;29(28):4544-55. doi: 10.1016/j.vaccine.2011.04.055. Epub 2011 May 5. Review.

PMID:
21549787
[PubMed - indexed for MEDLINE]
4.

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.

MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. Erratum in: MMWR Morb Mortal Wkly Rep. 2003 Feb 14;52(06):113.

PMID:
12825543
[PubMed - indexed for MEDLINE]
Free Article
5.

Yellow fever vaccination: how much is enough?

Massad E, Coutinho FA, Burattini MN, Lopez LF, Struchiner CJ.

Vaccine. 2005 Jun 10;23(30):3908-14. Epub 2005 Apr 2.

PMID:
15917112
[PubMed - indexed for MEDLINE]
6.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
[PubMed - indexed for MEDLINE]
7.

Risk of fatal adverse events associated with 17DD yellow fever vaccine.

Struchiner CJ, Luz PM, Dourado I, Sato HK, Aguiar SG, Ribeiro JG, Soares RC, Codeço CT.

Epidemiol Infect. 2004 Oct;132(5):939-46.

PMID:
15473158
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events.

Khromava AY, Eidex RB, Weld LH, Kohl KS, Bradshaw RD, Chen RT, Cetron MS; Yellow Fever Vaccine Safety Working Group.

Vaccine. 2005 May 9;23(25):3256-63.

PMID:
15837230
[PubMed - indexed for MEDLINE]
9.

Prevention of yellow fever in persons traveling to the tropics.

Monath TP, Cetron MS.

Clin Infect Dis. 2002 May 15;34(10):1369-78. Epub 2002 Apr 25. Review. Erratum in: Clin Infect Dis 2002 Jul 1;35(1):110.

PMID:
11981733
[PubMed - indexed for MEDLINE]
Free Article
10.

Review of the risks and benefits of yellow fever vaccination including some new analyses.

Monath TP.

Expert Rev Vaccines. 2012 Apr;11(4):427-48. doi: 10.1586/erv.12.6. Review.

PMID:
22551029
[PubMed - indexed for MEDLINE]
11.

[Yellow fever vaccination: update on rare and severe adverse effects].

Receveur MC, Bruyand M, Pistone T, Malvy D.

Med Mal Infect. 2009 Apr;39(4):234-41. doi: 10.1016/j.medmal.2008.11.013. Epub 2009 Jan 23. French.

PMID:
19167852
[PubMed - indexed for MEDLINE]
12.

Yellow fever vaccination: some thoughts on how much is enough [Vaccine 23 (2005) 3908-3914].

Martins RM, Galler R, Freire MS, Camacho LA, de Lourdes S Maia M, Homma A.

Vaccine. 2007 Jan 2;25(1):10-1. Epub 2006 Jan 18.

PMID:
16448728
[PubMed - indexed for MEDLINE]
13.

Evaluation of two yellow fever vaccines for routine immunization programs in Argentina.

Ripoll C, Ponce A, Wilson MM, Sharif N, Vides JB, Armoni J, Teuwen DE.

Hum Vaccin. 2008 Mar-Apr;4(2):121-6. Epub 2007 Oct 26.

PMID:
18382132
[PubMed - indexed for MEDLINE]
Free Article
14.

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010.

Breugelmans JG, Lewis RF, Agbenu E, Veit O, Jackson D, Domingo C, Böthe M, Perea W, Niedrig M, Gessner BD, Yactayo S; YF AEFI group.

Vaccine. 2013 Apr 3;31(14):1819-29. doi: 10.1016/j.vaccine.2013.01.054. Epub 2013 Feb 7.

PMID:
23395587
[PubMed - indexed for MEDLINE]
15.

Advanced age a risk factor for illness temporally associated with yellow fever vaccination.

Martin M, Weld LH, Tsai TF, Mootrey GT, Chen RT, Niu M, Cetron MS; GeoSentinel Yellow Fever Working Group.

Emerg Infect Dis. 2001 Nov-Dec;7(6):945-51.

PMID:
11747720
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Safety of the yellow Fever vaccine: a retrospective study.

Nordin JD, Parker ED, Vazquez-Benitez G, Kharbanda EO, Naleway A, Marcy SM, Molitor B, Kuckler L, Baggs J.

J Travel Med. 2013 Nov-Dec;20(6):368-73. doi: 10.1111/jtm.12070. Epub 2013 Oct 10.

PMID:
24118538
[PubMed - indexed for MEDLINE]
17.

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.

Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT.

Pediatr Infect Dis J. 2004 Apr;23(4):287-94. Review.

PMID:
15071280
[PubMed - indexed for MEDLINE]
18.

Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.

Niu MT, Ball R, Woo EJ, Burwen DR, Knippen M, Braun MM; VAERS Working Group.

Vaccine. 2009 Jan 7;27(2):290-7. doi: 10.1016/j.vaccine.2008.10.044. Epub 2008 Nov 6.

PMID:
18992783
[PubMed - indexed for MEDLINE]
19.

Anaphylaxis from yellow fever vaccine.

Kelso JM, Mootrey GT, Tsai TF.

J Allergy Clin Immunol. 1999 Apr;103(4):698-701.

PMID:
10200022
[PubMed - indexed for MEDLINE]
20.

Age-related risk of adverse events following yellow fever vaccination in Australia.

Lawrence GL, Burgess MA, Kass RB.

Commun Dis Intell Q Rep. 2004;28(2):244-8. Erratum in: Commun Dis Intell. 2004;28(3):348.

PMID:
15460963
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk